APUS
Apimeds Pharmaceuticals US Inc.

299
Mkt Cap
$38.11M
Volume
90,321.00
52W High
$4.03
52W Low
$1.37
PE Ratio
-7.03
APUS Fundamentals
Price
$2.61
Prev Close
$3.03
Open
$3.00
50D MA
$2.13
Beta
0.86
Avg. Volume
52,062.26
EPS (Annual)
-$0.1188
P/B
4.67
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
Apimeds Pharmaceuticals says I love my Ducks with new ai Futures Lab Program collaboration with the University of Oregons Lundquist College of Business
Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) (Apimeds) today announced the expansion of the Apimeds ai Futures Lab program through a new collaboration with the University of Oregons Lundquist...
Business Wire·1mo ago

Latest APUS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.